These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 120745)

  • 21. Treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of Azlocillin in premature and newborn infants (author's transl)].
    Heimann G; von Heereman B; Gladtke E
    Arzneimittelforschung; 1979; 29(12a):1949-51. PubMed ID: 543897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local tolerance of i.m. mezlocillin injection.
    Belli L; Gandolfo S; Varela M; Gennaro EA
    Arzneimittelforschung; 1979; 29(12a):1985-7. PubMed ID: 543907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial spectrum of mezlocillin and azlocillin, two new antibiotics of the ureidopenicillin group (author's transl)].
    Roy C; Segura C; Fuster C; Tirado M; Foz A
    Med Clin (Barc); 1982 May; 78(9):363-71. PubMed ID: 6212725
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.
    Tselentis J; Cordossis T; Kosmidis J; Lambropoulos S; Melissinos K
    J Antimicrob Chemother; 1981 Oct; 8(4):317-21. PubMed ID: 6271725
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience with mezlocillin in infections of mouth and jaw (author's transl)].
    Shimizu M; Amagasa M; Ohnishi M; Yuki K; Sato T; Yoshida H; Do K; Ueno M
    Arzneimittelforschung; 1979; 29(12a):1987-9. PubMed ID: 543908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The present situation of antibacterial resistance (author's transl)].
    Wagner WH
    Immun Infekt; 1978 Oct; 6(5):180-93. PubMed ID: 100410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mezlocillin and beta-lactamases (author's transl)].
    Labia R; Morand A
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):324-6. PubMed ID: 6460968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
    Shah PM; Schirmer KP; Helm EB; Stille W
    Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The basic studies on chemotherapy in urinary tract infection due to organisms with resistance to antibiotics (author's transl)].
    Igari J
    Jpn J Antibiot; 1977 Aug; 30(8):596-611. PubMed ID: 409865
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.
    Ohlsson H; Bergan T
    Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Probability of resistance to 10 standard- and 7 recently introduced antimicrobics in multiresistant strains of Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)].
    Schröter G; Hümpfner A
    Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):31-42. PubMed ID: 375624
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
    Wang R; Sun XD; Cai QM
    Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid penetration of mezlocillin.
    Modai J; Pierre J; Bergogne-Berezin E; Avril MF
    Arzneimittelforschung; 1979; 29(12a):1967-9. PubMed ID: 543903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behaviour of TEM-1 beta-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coli.
    Livermore DM; Moosdeen F; Lindridge MA; Kho P; Williams JD
    J Antimicrob Chemother; 1986 Feb; 17(2):139-46. PubMed ID: 3516962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combinations of mezlocillin with other antibiotics. A review of in vitro laboratory studies (author's transl)].
    Courtieu AL; Billaudel S; Drugeon HB; Chung SS
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):329-31. PubMed ID: 6460970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.